April 19 | 2023
December 06 | 2022
May 20 | 2022
May 13 | 2021
Q3 Virtual September 10, 2021
Our top executives presented our ArromerTM platform and how this new class of multimodal RNA therapeutics will simultaneously silence the right combination of disease targets.
Q3 Virtual September 10, 2021
Systems Oncology presented to registered investors our multimodal RNA therapeutics platform, ArromerTM, which can be harnessed to transform outcomes for any complex polygenic disease.
Passed Virtual October 27, 2020
Dr. Spyro Mousses will speak about "Target identification, validation & molecule generation" at 10:30am ET. Join us to learn the advancement of AI in drug development.
Q3 Virtual September 16, 2020
The AZBio Award will premiere on 9/16 on CW61 and re-air on 9/18 on ABC15. We are featured at 47 minutes into the 1-hour program. Watch it on demand here.
Q3 Virtual September 15 - 16, 2020
Registered investors will have exclusive access to our CEO, Dr. Spyro Mousses' video presentation, as well as the opportunity to set up one- to-one meetings with us.
Q3 Virtual August 17 - 20, 2020
Join us to learn about the latest research advancement in mathematical biology. Our AI Research Fellow Dr. Massey is a panelist for the pre-meeting mentoring program.
Q2 VIRTUAL June 08 - 12, 2020
Collaborating virtually alongside other biotechnology and pharmaceutical leaders!
Q2 Virtual May 29 - June 02, 2020
Join us to learn more about the latest cancer science at ASCO! Check out here to learn how we use AI to find novel synthetic lethal targets in caner!
Q2 Virtual April 27 - 28, 2020
AACR turns virtual, but our work continues! Read about our collaboration with Texas A&M and let's bring your discovery to the next level!
